{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:02:59Z","timestamp":1787583779322,"version":"build-2736575974"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Urol Rep"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s11934-013-0369-y","type":"journal-article","created":{"date-parts":[[2013,10,7]],"date-time":"2013-10-07T08:59:07Z","timestamp":1381136347000},"page":"442-447","source":"Crossref","is-referenced-by-count":23,"title":["Current Recommendations for Bladder Instillation Therapy in the Treatment of Interstitial Cystitis\/Bladder Pain Syndrome"],"prefix":"10.1007","volume":"14","author":[{"given":"Marc A.","family":"Colaco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,10,8]]},"reference":[{"key":"369_CR1","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/j.juro.2011.03.064","volume":"185","author":"PM Hanno","year":"2011","unstructured":"\u2022\u2022 Hanno PM et al. AUA guideline for the diagnosis and treatment of interstitial cystitis\/bladder pain syndrome. J Urol. 2011;185:2162\u201370. This document reflects all the current guidelines and recommendations from the AUA regarding interstitial cystitis\/bladder pain syndrome.","journal-title":"J Urol"},{"key":"369_CR2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0090-4295(78)90118-8","volume":"11","author":"SW Shirley","year":"1978","unstructured":"Shirley SW, Stewart BH, Mirelman S. Dimethyl sulfoxide in treatment of inflammatory genitourinary disorders. Urology. 1978;11:215\u201320.","journal-title":"Urology"},{"key":"369_CR3","first-page":"937061","volume":"2011","author":"R Kim","year":"2011","unstructured":"Kim R, Liu W, Chen X, Kreder KJ, Luo Y. Intravesical dimethyl sulfoxide inhibits acute and chronic bladder inflammation in transgenic experimental autoimmune cystitis models. J Biomed Biotechnol. 2011;2011:937061.","journal-title":"J Biomed Biotechnol"},{"key":"369_CR4","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/sj.bjp.0707317","volume":"151","author":"K Shiga","year":"2007","unstructured":"Shiga K et al. Dimethyl sulphoxide relaxes rabbit detrusor muscle by decreasing the Ca2+ sensitivity of the contractile apparatus. Br J Pharmacol. 2007;151:1014\u201324.","journal-title":"Br J Pharmacol"},{"key":"369_CR5","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.urology.2006.08.1105","volume":"69","author":"RM Moldwin","year":"2007","unstructured":"Moldwin RM, Evans RJ, Stanford EJ, Rosenberg MT. Rational approaches to the treatment of patients with interstitial cystitis. Urology. 2007;69:S73\u201381.","journal-title":"Urology"},{"key":"369_CR6","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000472470","volume":"11","author":"G Hohlbrugger","year":"1985","unstructured":"Hohlbrugger G, Lentsch P. Intravesical ions, osmolality and pH influence the volume pressure response in the normal rat bladder, and this is more pronounced after DMSO exposure. Eur Urol. 1985;11:127\u201330.","journal-title":"Eur Urol"},{"key":"369_CR7","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.urology.2012.03.030","volume":"80","author":"K Stav","year":"2012","unstructured":"Stav K, Beberashvili I, Lindner A, Leibovici D. Predictors of response to intravesical dimethyl-sulfoxide cocktail in patients with interstitial cystitis. Urology. 2012;80:61\u20135.","journal-title":"Urology"},{"key":"369_CR8","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0090-4295(97)00181-7","volume":"49","author":"J Parkin","year":"1997","unstructured":"Parkin J, Shea C, Sant GR. Intravesical dimethyl sulfoxide (DMSO) for interstitial cystitis\u2013a practical approach. Urology. 1997;49:105\u20137.","journal-title":"Urology"},{"key":"369_CR9","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1464-410X.1987.tb04805.x","volume":"59","author":"SB Barker","year":"1987","unstructured":"Barker SB, Matthews PN, Philip PF, Williams G. Prospective study of intravesical dimethyl sulphoxide in the treatment of chronic inflammatory bladder disease. Br J Urol. 1987;59:142\u20134.","journal-title":"Br J Urol"},{"key":"369_CR10","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/BF00211416","volume":"11","author":"GM Ghoniem","year":"1993","unstructured":"Ghoniem GM, McBride D, Sood OP, Lewis V. Clinical experience with multiagent intravesical therapy in interstitial cystitis patients unresponsive to single-agent therapy. World J Urol. 1993;11:178\u201382.","journal-title":"World J Urol"},{"key":"369_CR11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/00365590410018738","volume":"39","author":"J R\u00f6ssberger","year":"2005","unstructured":"R\u00f6ssberger J, Fall M, Peeker R. Critical appraisal of dimethyl sulfoxide treatment for interstitial cystitis: discomfort, side-effects and treatment outcome. Scand J Urol Nephrol. 2005;39:73\u20137.","journal-title":"Scand J Urol Nephrol"},{"key":"369_CR12","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0022-5347(17)41478-9","volume":"140","author":"R Perez-Marrero","year":"1988","unstructured":"\u2022 Perez-Marrero R, Emerson LE, Feltis JT. A controlled study of dimethyl sulfoxide in interstitial cystitis. J Urol. 1988;140:36\u20139. One of the main randomized clinical trials showing the efficacy of DMSO.","journal-title":"J Urol"},{"key":"369_CR13","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1016\/S0022-5347(05)66916-9","volume":"164","author":"R Peeker","year":"2000","unstructured":"\u2022 Peeker R, Haghsheno MA, Holm\u00e4ng S, Fall M. Intravesical bacillus Calmette-Guerin and dimethyl sulfoxide for treatment of classic and nonulcer interstitial cystitis: a prospective, randomized double-blind study. J Urol. 2000;164:1912\u20135. discussion 1915\u20131916. One of the main randomized clinical trials showing the efficacy of DMSO.","journal-title":"J Urol"},{"key":"369_CR14","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1097\/01.ju.0000118938.09119.a5","volume":"171","author":"G Slobodov","year":"2004","unstructured":"Slobodov G et al. Abnormal expression of molecular markers for bladder impermeability and differentiation in the urothelium of patients with interstitial cystitis. J Urol. 2004;171:1554\u20138.","journal-title":"J Urol"},{"key":"369_CR15","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0090-4295(96)00322-6","volume":"48","author":"RE Hurst","year":"1996","unstructured":"Hurst RE et al. A deficit of chondroitin sulfate proteoglycans on the bladder uroepithelium in interstitial cystitis. Urology. 1996;48:817\u201321.","journal-title":"Urology"},{"key":"369_CR16","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0090-4295(78)90291-1","volume":"12","author":"PM Hanno","year":"1978","unstructured":"Hanno PM, Fritz R, Wein AJ, Mulholland SG. Heparin as antibacterial agent in rabbit bladder. Urology. 1978;12:411\u20135.","journal-title":"Urology"},{"key":"369_CR17","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2490-5-4","volume":"5","author":"KD Kyker","year":"2005","unstructured":"Kyker KD, Coffman J, Hurst RE. Exogenous glycosaminoglycans coat damaged bladder surfaces in experimentally damaged mouse bladder. BMC Urol. 2005;5:4.","journal-title":"BMC Urol"},{"key":"369_CR18","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJM199307083290212","volume":"329","author":"DA Lane","year":"1993","unstructured":"Lane DA, Adams L. Non-anticoagulant uses of heparin. N Engl J Med. 1993;329:129\u201330.","journal-title":"N Engl J Med"},{"key":"369_CR19","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1464-410X.1994.tb07634.x","volume":"73","author":"CL Parsons","year":"1994","unstructured":"\u2022 Parsons CL, Housley T, Schmidt JD, Lebow D. Treatment of interstitial cystitis with intravesical heparin. Br J Urol. 1994;73:504\u20137. The first major study demonstrating the efficacy of intravesicular heparin.","journal-title":"Br J Urol"},{"key":"369_CR20","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.urology.2004.08.056","volume":"65","author":"CL Parsons","year":"2005","unstructured":"Parsons CL. Successful downregulation of bladder sensory nerves with combination of heparin and alkalinized lidocaine in patients with interstitial cystitis. Urology. 2005;65:45\u20138.","journal-title":"Urology"},{"key":"369_CR21","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s00192-009-0897-7","volume":"20","author":"CW Butrick","year":"2009","unstructured":"Butrick CW, Sanford D, Hou Q, Mahnken JD. Chronic pelvic pain syndromes: clinical, urodynamic, and urothelial observations. Int Urogynecol J Pelvic Floor Dysfunct. 2009;20:1047\u201353.","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"369_CR22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.urology.2007.09.067","volume":"71","author":"BK Welk","year":"2008","unstructured":"Welk BK, Teichman JMH. Dyspareunia response in patients with interstitial cystitis treated with intravesical lidocaine, bicarbonate, and heparin. Urology. 2008;71:67\u201370.","journal-title":"Urology"},{"key":"369_CR23","unstructured":"Interstitial Cystitis Association. Bioniche trial. 2003."},{"key":"369_CR24","unstructured":"Reece JB, Urry L, Cain M, Wasserman S, Minorsky P, Jackson R. Campbell biology (9th edition; International edition.). Harlow: Pearson Education; 2011."},{"key":"369_CR25","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.juro.2007.08.170","volume":"179","author":"EL Davis","year":"2008","unstructured":"Davis EL, El Khoudary SR, Talbott EO, Davis J, Regan LJ. Safety and efficacy of the use of intravesical and oral pentosan polysulfate sodium for interstitial cystitis: a randomized double-blind clinical trial. J Urol. 2008;179:177\u201385.","journal-title":"J Urol"},{"key":"369_CR26","unstructured":"Henry RA. Re: safety and efficacy of the use of intravesical and oral pentosan polysulfate sodium for interstitial cystitis: a randomized double-blind clinical trial. Davis EL, El Khoudary SR, Talbott EO, Davis J, Regan LJ. J Urol 2008; 179: 177\u2013185. J Urol. 180, 411\u2013412; author reply 412\u2013413 (2008)."},{"key":"369_CR27","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1464-410X.2008.08028.x","volume":"103","author":"JC Nickel","year":"2009","unstructured":"Nickel JC et al. A real-life multicentre clinical practice study to evaluate the efficacy and safety of intravesical chondroitin sulphate for the treatment of interstitial cystitis. BJU Int. 2009;103:56\u201360.","journal-title":"BJU Int"},{"key":"369_CR28","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1464-410X.2008.08162.x","volume":"103","author":"JC Nickel","year":"2009","unstructured":"\u2022 Nickel JC et al. Intravesical alkalinized lidocaine (PSD597) offers sustained relief from symptoms of interstitial cystitis and painful bladder syndrome. BJU Int. 2009;103:910\u20138. The major study in the demonstrating the efficacy of intravesicular lidocaine.","journal-title":"BJU Int"},{"key":"369_CR29","doi-asserted-by":"crossref","first-page":"143ra100","DOI":"10.1126\/scitranslmed.3003804","volume":"4","author":"JC Nickel","year":"2012","unstructured":"Nickel JC et al. Continuous intravesical lidocaine treatment for interstitial cystitis\/bladder pain syndrome: safety and efficacy of a new drug delivery device. Sci Transl Med. 2012;4:143ra100.","journal-title":"Sci Transl Med"},{"key":"369_CR30","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.juro.2007.11.037","volume":"179","author":"W Boucher","year":"2008","unstructured":"Boucher W et al. Intravesical nanocrystalline silver decreases experimental bladder inflammation. J Urol. 2008;179:1598\u2013602.","journal-title":"J Urol"},{"key":"369_CR31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00005392-199907000-00002","volume":"162","author":"MB Chancellor","year":"1999","unstructured":"Chancellor MB, De Groat WC. Intravesical capsaicin and resiniferatoxin therapy: spicing up the ways to treat the overactive bladder. J Urol. 1999;162:3\u201311.","journal-title":"J Urol"},{"key":"369_CR32","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1097\/01.ju.0000154631.92150.ef","volume":"173","author":"CK Payne","year":"2005","unstructured":"Payne CK et al. Intravesical resiniferatoxin for the treatment of interstitial cystitis: a randomized, double-blind, placebo controlled trial. J Urol. 2005;173:1590\u20134.","journal-title":"J Urol"},{"key":"369_CR33","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00192-005-1307-4","volume":"16","author":"TYH Chen","year":"2005","unstructured":"Chen TYH, Corcos J, Camel M, Ponsot Y, Tu LM. Prospective, randomized, double-blind study of safety and tolerability of intravesical resiniferatoxin (RTX) in interstitial cystitis (IC). Int Urogynecol J Pelvic Floor Dysfunct. 2005;16:293\u20137.","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"369_CR34","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1016\/S0022-5347(01)64682-2","volume":"157","author":"K Peters","year":"1997","unstructured":"Peters K et al. The efficacy of intravesical Tice strain bacillus Calmette-Guerin in the treatment of interstitial cystitis: a double-blind, prospective, placebo controlled trial. J Urol. 1997;157:2090\u20134.","journal-title":"J Urol"},{"key":"369_CR35","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1097\/00005392-199805000-00019","volume":"159","author":"KM Peters","year":"1998","unstructured":"Peters KM, Diokno AC, Steinert BW, Gonzalez JA. The efficacy of intravesical bacillus Calmette-Guerin in the treatment of interstitial cystitis: long-term followup. J Urol. 1998;159:1483\u20136. discussion 1486\u20131487.","journal-title":"J Urol"},{"key":"369_CR36","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1097\/01.ju.0000152337.82806.e8","volume":"173","author":"R Mayer","year":"2005","unstructured":"Mayer R et al. A randomized controlled trial of intravesical bacillus calmette-guerin for treatment refractory interstitial cystitis. J Urol. 2005;173:1186\u201391.","journal-title":"J Urol"},{"key":"369_CR37","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0022-5347(17)35824-X","volume":"150","author":"JK Izes","year":"1993","unstructured":"Izes JK, Bihrle 3rd W, Thomas CB. Corticosteroid-associated fatal mycobacterial sepsis occurring 3 years after instillation of intravesical bacillus Calmette-Guerin. J Urol. 1993;150:1498\u2013500.","journal-title":"J Urol"},{"key":"369_CR38","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0022-5347(17)37316-0","volume":"147","author":"DL Lamm","year":"1992","unstructured":"Lamm DL et al. Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer. J Urol. 1992;147:596\u2013600.","journal-title":"J Urol"},{"key":"369_CR39","unstructured":"Nickel JC. Placebo controlled study of safety, tolerability, and efficacy of LiRIS in women with interstitial cystitis, followed by open-label extension. IN: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000. Available from: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01475253. Cited 2013 Sept"},{"key":"369_CR40","unstructured":"Haifler M, Assaf-Harofeh Medical Center. DMSO Efficacy in IC\/PBS patients during and after treatment IN: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000. Available from: http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01074567. NCT identifier:01074567. Cited 2013 Sept."},{"key":"369_CR41","doi-asserted-by":"crossref","unstructured":"Fraser MO, Chuang YC, Tyagi P, et al. Intravesical liposome administration \u2013 a novel treatment for hyperactive bladder in the rat. Urology. 2003;61:656\u2013663.","DOI":"10.1016\/S0090-4295(02)02281-1"},{"key":"369_CR42","doi-asserted-by":"crossref","unstructured":"Chuang YC, Lee WC, Chiang PH. Intravesical liposome versus oral pentosan polysulfate for interstitial cystitis\/painful bladder syndrome. J. Urol. 2009;182:1393\u20131400.","DOI":"10.1016\/j.juro.2009.06.024"},{"key":"369_CR43","unstructured":"Kaufman J, Lipella Pharmaceuticals Inc. Efficacy of Intravesical LP08 in patients with interstitial cystitis\/painful bladder syndrome. IN: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000. Available from: http:\/\/clinicaltrials.gov\/show\/NCT01393223. NCT identifier: 01393223. Cited 2013 Sept"},{"key":"369_CR44","unstructured":"Parsons CL. Evidence-based strategies for recognizing and managing interstitial cystitis. Contemp. Urol. 2003;15(2):22\u201335"}],"container-title":["Current Urology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-013-0369-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11934-013-0369-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-013-0369-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T21:09:36Z","timestamp":1564434576000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11934-013-0369-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["369"],"URL":"https:\/\/doi.org\/10.1007\/s11934-013-0369-y","relation":{},"ISSN":["1527-2737","1534-6285"],"issn-type":[{"value":"1527-2737","type":"print"},{"value":"1534-6285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}